The healthcare business is of Rs 4.35 lakh crore. She did bachelor's in Economics from the Wharton School of the University ...

Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken Chairman & Managing Director of Sun Pharma has turned the company from a ...

In his 42-year journey of building Sun Pharma from the ground up, there is only one thing Dilip Shanghvi would do differently. “Sometimes I would have got angry… That I wouldn’t have wanted ...

Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

The company projects revenue growth of mid- to high single digits in FY26 compared with an 8.5% increase in FY25 ...

Sun Pharmaceutical Industries announces a USD 100 million investment to commercialize new speciality products, strengthening ...

Sun Pharma plans a $100 million investment to commercialize innovative products, including Unloxcyt and Leqselvi, aiming for ...

Officially completing its acquisition of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Sun Pharmaceutical Industries Ltd. has ...

Sun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, ...

Vidhi Shanghvi is the daughter of Dilip Shanghvi. She plays an important role in Sun Pharmaceutical Industries along with brother Aalok Shanghvi. The healthcare business is of Rs 4.35 lakh crore.